Mmr (Measles, Mumps, Rubella) Vaccine Suppliers & Bulk Manufacturers
Available Forms: Pre-filled syringes. Vials (lyophilized powder for reconstitution)
Available Strengths: ose equivalent to 10 or 20 doses per vial
Reference Brands: M-M-R II. Priorix(US)
Category:
Vaccines
MMR vaccine stimulates immunity by introducing weakened viruses, prompting the body to produce protective antibodies against measles, mumps, and rubella. It prevents these serious diseases, reduces transmission, and protects communities. Benefits include lifelong immunity, disease elimination, and safeguarding vulnerable populations, supporting global public health efforts.
MMR (Measles, Mumps, Rubella) Vaccine is available in Pre-filled syringes. Vials (lyophilized powder for reconstitution)
and strengths such as ose equivalent to 10 or 20 doses per vial.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, MMR (Measles, Mumps, Rubella) Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
MMR (Measles, Mumps, Rubella) Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
MMR (Measles, Mumps, Rubella) vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves clinical evaluation and safety data, while in the EU, CE marking certifies conformity with in vitro diagnostic and vaccine regulations. These vaccines undergo validation, stability testing, and quality audits, with comprehensive documentation including clinical trial data, safety profiles, and manufacturing details. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees access to safe, effective immunizations vital for disease eradication efforts worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing